Leiomyoma Ablation with Ultrasonography-Guided Radiofrequency: A Report of Four Cases

Abstract

Objective: This study aims to report the successful application of transvaginal ultrasound-guided radiofrequency ablation (RFA) as a minimally invasive therapy in four women with symptomatic intramural and subserous leiomyomas using a standard protocol. Methods: A report of four cases. Case: A case report of four patients was conducted at Soerojo Hospital, Magelang, from September 2021 to January 2022. The fi rst case involved a premenopausal woman experiencing pelvic discomfort. The second case underwent curettage after a diagnosis of a blighted ovum; the third case presented with non-cyclic pain and irregular cycles, while the fourth case had a history of 14-yearold infertility and repeated IVF failures. Three out of the four women with leiomyomas in this report experienced heavy menstrual bleeding. No signifi cant side effects or complications occurred during or after the treatment. Uterine leiomyoma size was monitored for one week and three months, showing an average reduction of 56.9%, indicating a signifi cant decrease in myoma volume. Additionally, the reported symptoms showed improvement. Conclusion: Transvaginal ultrasound-guided radiofrequency ablation proves to be an effective and minimally invasive therapy with minor side effects, making it a promising primary choice for leiomyoma treatment.